Luke Greenwalt, MBA, on "Entering a Brave New World" | Asembia's AXS25 Summit
The vice president and market lead of IQVIA's Market Center of Excellence gives some insight intot the title of his talk today at Asembia meeting.
In an interview with Managed Healthcare Executive (MHE), Luke Greenwalt, MBA, vice president and lead of the Market Access Center of Excellence of IQVIA, discusses broad trends in the pharmaceutical market. Greenwalt, who is a member of the MHE editorial advisory board, described the system as a mature one, with three pharmacy benefit members (PBMs) controlling 80% of the prescription market, three wholesalers controlling 90% of distribution and four retail pharmacy chains controlling more than half of retail sales. Now with the Trump administration, major policy changes are possible in the form of tariffs and international pricing.
"It's hard for the big to get any bigger, so we're looking at a marketplace that's going to change pretty dramatically in the next few years," Greenwalt said.
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look for ways to slash government spending as a way of offsetting major tax cuts.
Read More
